Proteomics

Dataset Information

0

ERAP2 Increases the Abundance of a Peptide Submotif Highly Selective for the Birdshot Uveitis-Associated HLA-A29


ABSTRACT: Birdshot Uveitis (BU) is a blinding inflammatory eye condition that only affects HLA-A29-positive individuals. Genetic association studies linked ERAP2 with BU, an aminopeptidase which trims peptides before their presentation by HLA class I at the cell surface, which suggests that ERAP2-dependent peptide presentation by HLA-A29 drives the pathogenesis of BU. However, it remains poorly understood whether the effects of ERAP2 on the HLA-A29 peptidome are distinct from its effect on other HLA allotypes. To address this, we focused on the effects of ERAP2 on the immunopeptidome in patientderived antigen presenting cells. Using complementary HLA-A29-based and pan-class I immunopurifications, isotope-labeled naturally processed and presented HLA-bound peptides were sequenced by mass spectrometry. We show that the effects of ERAP2 on the N-terminus of ligands of HLA-A29 are shared across endogenous HLA allotypes, but discover and replicate that one peptide motif generated in the presence of ERAP2 is specifically bound by HLA-A29. This motif can be found in the amino acid sequence of putative autoantigens. We further show evidence for internal sequence specificity for ERAP2 imprinted in the immunopeptidome. These results reveal that ERAP2 can generate an HLA-A29-specific antigen repertoire, which supports that antigen presentation is a key disease pathway in BU.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): B Cell, Ebv-lcl Cell

DISEASE(S): Birdshot Chorioretinopathy

SUBMITTER: W.J. Venema  

LAB HEAD: Jonas J.W. Kuiper

PROVIDER: PXD024109 | Pride | 2021-09-10

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
L20182002400a.raw Raw
L20182002400b.raw Raw
L20182002400c.raw Raw
L20182002401a.raw Raw
L20182002401b.raw Raw
Items per page:
1 - 5 of 40
altmetric image

Publications


Birdshot Uveitis (BU) is a blinding inflammatory eye condition that only affects HLA-A29-positive individuals. Genetic association studies linked <i>ERAP2</i> with BU, an aminopeptidase which trims peptides before their presentation by HLA class I at the cell surface, which suggests that ERAP2-dependent peptide presentation by HLA-A29 drives the pathogenesis of BU. However, it remains poorly understood whether the effects of ERAP2 on the HLA-A29 peptidome are distinct from its effect on other HL  ...[more]

Similar Datasets

2024-07-15 | PXD046825 | Pride
2019-09-25 | PXD014804 | Pride
2022-02-17 | PXD027408 | Pride
2023-10-24 | PXD044235 | Pride
2022-02-15 | PXD028985 | Pride
| PRJNA1048747 | ENA
2012-06-18 | E-GEOD-38798 | biostudies-arrayexpress
2021-04-01 | GSE163067 | GEO
2012-06-19 | GSE38798 | GEO
2020-09-02 | PXD020011 | Pride